{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:41:37Z","timestamp":1792683697832,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002327","name":"Kela","doi-asserted-by":"publisher","award":["The Social Insurance Institution of Finland (76\/26\/2021)"],"award-info":[{"award-number":["The Social Insurance Institution of Finland (76\/26\/2021)"]}],"id":[{"id":"10.13039\/501100002327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"DOI":"10.1007\/s40272-026-00781-2","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:57:19Z","timestamp":1792681039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eight-Year Trends in Nationwide Proton Pump Inhibitor Use Among Finnish Children Under 6 Years by Sector and Specialty"],"prefix":"10.1007","author":[{"given":"Laura","family":"R\u00e4is\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Csonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juho","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Koskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2061-2552","authenticated-orcid":false,"given":"Heini","family":"Kari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"781_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0000000000003063","volume":"72","author":"R Orel","year":"2021","unstructured":"Orel R, Benninga MA, Broekaert IJ, et al. Drugs in focus: proton pump inhibitors. J Pediatr Gastroenterol Nutr. 2021;72:645\u201353.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"781_CR2","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.cgh.2025.01.016","volume":"23","author":"AJ Lucendo","year":"2025","unstructured":"Lucendo AJ, Guti\u00e9rrez-Ram\u00edrez L, Tejera-Mu\u00f1oz A, et al. Proton pump inhibitors for inducing and maintaining remission in eosinophilic esophagitis: an updated systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2025;23:2115-2127.e21.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"781_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","volume":"15","author":"RM Ward","year":"2013","unstructured":"Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Pediatr Drugs. 2013;15:119\u201331.","journal-title":"Pediatr Drugs"},{"key":"781_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaad.2016.02.1239","volume":"76","author":"A Caplan","year":"2017","unstructured":"Caplan A, Fett N, Rosenbach M, et al. Prevention and management of glucocorticoid-induced side effects: a comprehensive review. J Am Acad Dermatol. 2017;76:11\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"781_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40264-024-01502-9","volume":"48","author":"N Brusselaers","year":"2025","unstructured":"Brusselaers N, Gudnadottir U, Engstrand L, et al. Trends in proton pump inhibitor use in Sweden by sex and age: a drug utilisation study. Drug Saf. 2025;48:389\u2013400.","journal-title":"Drug Saf"},{"key":"781_CR6","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1111\/apa.16491","volume":"111","author":"M Lyamouri","year":"2007","unstructured":"Lyamouri M, M\u00e5rild K, Nielsen RG, et al. Proton pump inhibitors for infants in three Scandinavian countries increased from 2007 to 2020 despite international recommendations. Acta Paediatr. 2007;111:2222\u20138.","journal-title":"Acta Paediatr"},{"key":"781_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100129","volume":"7","author":"M Taine","year":"2021","unstructured":"Taine M, Offredo L, Dray-Spira R, et al. Paediatric outpatient prescriptions in France between 2010 and 2019: a nationwide population-based study. Lancet Reg Health Eur. 2021;7:100129.","journal-title":"Lancet Reg Health Eur"},{"key":"781_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/MPG.0000000000001596","volume":"65","author":"M-L Blank","year":"2017","unstructured":"Blank M-L, Parkin L. National study of off-label proton pump inhibitor use among New Zealand infants in the first year of life (2005\u20132012). J Pediatr Gastroenterol Nutr. 2017;65:179\u201384.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"781_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/jpc.12760","volume":"51","author":"S Hua","year":"2015","unstructured":"Hua S, Peters RL, Allen KJ, et al. Medical intervention in parent-reported infant gastro-oesophageal reflux: a population-based study. J Paediatr Child Health. 2015;51:515\u201323.","journal-title":"J Paediatr Child Health"},{"key":"781_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12887-020-02047-3","volume":"20","author":"M Curien-Chotard","year":"2020","unstructured":"Curien-Chotard M, Jantchou P. Natural history of gastroesophageal reflux in infancy: new data from a prospective cohort. BMC Pediatr. 2020;20:152.","journal-title":"BMC Pediatr"},{"key":"781_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40272-012-0004-2","volume":"15","author":"SJ Czinn","year":"2013","unstructured":"Czinn SJ, Blanchard S. Gastroesophageal reflux disease in neonates and infants: when and how to treat. Paediatr Drugs. 2013;15:19\u201327.","journal-title":"Paediatr Drugs"},{"key":"781_CR12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/phar.1299","volume":"33","author":"JA Tjon","year":"2013","unstructured":"Tjon JA, Pe M, Soscia J, et al. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy. 2013;33:956\u201371.","journal-title":"Pharmacotherapy"},{"key":"781_CR13","volume":"8","author":"MP Tighe","year":"2023","unstructured":"Tighe MP, Andrews E, Liddicoat I, et al. Pharmacological treatment of gastro-oesophageal reflux in children. Cochrane Database Syst Rev. 2023;8:CD008550.","journal-title":"Cochrane Database Syst Rev"},{"key":"781_CR14","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1542\/peds.2010-2719","volume":"127","author":"RJ van der Pol","year":"2011","unstructured":"van der Pol RJ, Smits MJ, van Wijk MP, et al. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: a systematic review. Pediatrics. 2011;127:925\u201335.","journal-title":"Pediatrics"},{"key":"781_CR15","doi-asserted-by":"crossref","unstructured":"King E, Horn D, Gluchowski N, et al. Safety and effi cacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease. Cochrane Database Syst Rev. 2025;3(3):CD015127.","DOI":"10.1002\/14651858.CD015127.pub2"},{"key":"781_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M, et al. Pediatric gastroesophageal reflux clinical practice guidelines. J Pediatr Gastroenterol Nutr. 2018;66:516\u201354.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"781_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamapediatrics.2013.2911","volume":"168","author":"R Rosen","year":"2014","unstructured":"Rosen R. Gastroesophageal reflux in infants: more than just a phenomenon. JAMA Pediatr. 2014;168:83\u20139.","journal-title":"JAMA Pediatr"},{"key":"781_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1001\/jamapediatrics.2023.2900","volume":"177","author":"M Lassalle","year":"2023","unstructured":"Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023;177:1028\u201338.","journal-title":"JAMA Pediatr"},{"key":"781_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamapediatrics.2020.0007","volume":"174","author":"Y-H Wang","year":"2020","unstructured":"Wang Y-H, Wintzell V, Ludvigsson JF, et al. Association between proton pump inhibitor use and risk of fracture in children. JAMA Pediatr. 2020;174:543.","journal-title":"JAMA Pediatr"},{"key":"781_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/archdischild-2017-314026","volume":"103","author":"P De Bruyne","year":"2018","unstructured":"De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103:78\u201382.","journal-title":"Arch Dis Child"},{"key":"781_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65:740\u20138.","journal-title":"Gut"},{"key":"781_CR22","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","volume":"25","author":"G Bruno","year":"2019","unstructured":"Bruno G, Zaccari P, Rocco G, et al. Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified. World J Gastroenterol. 2019;25:2706\u201319.","journal-title":"World J Gastroenterol"},{"key":"781_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.839972","volume":"13","author":"V Dipasquale","year":"2022","unstructured":"Dipasquale V, Cicala G, Spina E, et al. A narrative review on efficacy and safety of proton pump inhibitors in children. Front Pharmacol. 2022;13:839972.","journal-title":"Front Pharmacol"},{"key":"781_CR24","doi-asserted-by":"publisher","first-page":"1157547","DOI":"10.3389\/fped.2023.1157547","volume":"11","author":"L R\u00e4is\u00e4nen","year":"2023","unstructured":"R\u00e4is\u00e4nen L, Viljakainen H, Kolho K-L. Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases. Front Pediatr. 2023;11:1157547.","journal-title":"Front Pediatr"},{"key":"781_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163647","volume":"15","author":"AC Pantazi","year":"2023","unstructured":"Pantazi AC, Balasa AL, Mihai CM, et al. Development of gut microbiota in the first 1000 days after birth and potential interventions. Nutrients. 2023;15:3647.","journal-title":"Nutrients"},{"key":"781_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885.","journal-title":"PLoS Med"},{"key":"781_CR27","unstructured":"Statistics Finland. Population by age and sex in population projections for different years, whole country. https:\/\/pxdata.stat.fi\/PxWeb\/pxweb\/en\/StatFin\/StatFin__vaenn\/statfin_vaenn_pxt_128t.px\/. Accessed 1 Feb 2026."},{"key":"781_CR28","unstructured":"ATC\/DDD Index 2026 n.d. https:\/\/atcddd.fhi.no\/atc_ddd_index\/. Accessed 8 Feb 2026."},{"key":"781_CR29","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/bcpt.13191","volume":"124","author":"I Aznar-Lou","year":"2019","unstructured":"Aznar-Lou I, Reilev M, L\u00f8drup AB, et al. Use of proton pump inhibitors among Danish children: a 16-year register-based nationwide study. Basic Clin Pharmacol Toxicol. 2019;124:704\u201310.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"781_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2025.114628","volume":"283","author":"S Hirsch","year":"2025","unstructured":"Hirsch S, Liu E, Nurko S, et al. Ten-year trends in pharmacologic management of gastroesophageal reflux disease and pediatric feeding disorders in young children. J Pediatr. 2025;283:114628.","journal-title":"J Pediatr"},{"key":"781_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.58366","volume":"8","author":"D Zhang","year":"2025","unstructured":"Zhang D, Stein R, Lu Y, et al. Pediatric gastrointestinal tract outcomes during the postacute phase of COVID-19. JAMA Netw Open. 2025;8:e2458366.","journal-title":"JAMA Netw Open"},{"key":"781_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doad064","volume":"37","author":"K Pelzner","year":"2024","unstructured":"Pelzner K, Fuchs C, Petersen M, et al. Sex- and gender-specific differences in symptoms and health-related quality of life among patients with gastroesophageal reflux disease. Dis Esophagus. 2024;37:doad064.","journal-title":"Dis Esophagus"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00781-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00781-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:57:21Z","timestamp":1792681041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00781-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":32,"alternative-id":["781"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00781-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to declare.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to legal restrictions and data protection regulations of the administrative sources providing individual-level register data, the authors do not have the permission to make sensitive personal data available. Interested parties may apply for permissions to access the data from the centralized data permit authority Findata (\n                      \n                      ), info@findata.fi.","order":2,"name":"Ethics","label":"Availability of Data","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Laura R\u00e4is\u00e4nen: Conceptualization, Methodology, Writing\u2014original draft, Writing\u2014review & editing; P\u00e9ter Csonka: Conceptualization, Methodology, Writing\u2014original draft, Writing\u2014review & editing; Juho Lepp\u00e4nen: Methodology, Data curation, Formal analysis, Generating Figures, Writing\u2014review & editing; Hanna Koskinen: Conceptualization, Methodology, Writing\u2014review & editing; Heini Kari: Conceptualization, Methodology, Project administration, Writing\u2014review & editing.","order":6,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}